טוען...
Reparixin, a CXCR1/2 inhibitor in islet allotransplantation
Quality of life in Type 1 diabetic patients may be improved with islet transplantation, but lifelong immunosuppression is required to prevent rejection. Allo-immune response is a key player in graft dysfunction and although the adaptive immune response is well characterized, the effect of the innate...
שמור ב:
| הוצא לאור ב: | Islets |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5029202/ https://ncbi.nlm.nih.gov/pubmed/27328412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19382014.2016.1199303 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|